Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAXTER HLTHCARE

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 39
  • 0 comments

FDA approve CYCLOPHOSPHAMIDE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 43
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text

ALEMBIC

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 46
  • 0 comments

FDA approve ALBENDAZOLE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 44
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text

UNICHEM

  • FDA Approval
  • Sept. 06, 2024, 04:15 UTC
  • 48
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 46
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

NOVARTIS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 40
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 44
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

HENGRUI PHARMA

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 42
  • 0 comments

FDA approve CASPOFUNGIN ACETATE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Sept. 05, 2024, 08:43 UTC
  • 47
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text
  • Previous
  • 316
  • 317
  • 318
  • 319
  • 320
  • Next

Search

News categories

  • Technical Exchange News(10613)
  • Event(2032)
  • SEC News(185160)
  • FDA Approval(9858)
  • Company Report(721)
  • Business News(122568)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin